Enumeral Biomed Revenue, Profits - ENUMQ Annual Income Statement

Add to My Stocks
$0 $0 (0%) ENUMQ stock closing price May 31, 2018 (Closing)

Financial analysis of Enumeral Biomed involves more than just checking the Enumeral Biomed stock price, by looking at the financial statements of the company in detail. An income statement is one of the three key financial statements furnished by a company, the other two being the balance sheet and the cashflow statement. The income statement for ENUMQ which shows a YOY revenue growth of 65.54% is specific to a period of time. Investors typically check YoY or QoQ revenue growth. The Enumeral Biomed profit and loss statement for 2016 shows a net profit of $-11.85M. Profits for last year was $3.29M. Apart from this an investor should also check Enumeral Biomed assets and Enumeral Biomed free cash flow.

View revenue and profit details for latest and last 10 financial years.
show more
Fiscal year is Jan - Dec20162015201420132012
Enumeral Biomed Revenues or Net Sales
2.45M1.48M---
Cost Of Goods Sold (COGS)-----
Enumeral Biomed Gross Profit
2.45M1.48M---
Research & Development Expense4.86M6.49M3.57M2.36M-
Selling General & Admin Expense4.56M5.69M3.01M1.83M-
Income Before Depreciation Depletion Amortization-6.97M-10.7M-6.43M-3.75M-
Depreciation Depletion Amortization-----
Non Operating Income-4.88M13.99M-1.5M--
Interest Expense-----
Enumeral Biomed Pretax Income
-11.85M3.29M-8.17M-3.86M-
Provision for Income Taxes-----
MinorityInterest-----
Investment Gains Losses-----
Other Income-----
Income Before Extraordinaries & Disc Operations-11.85M3.29M-8.17M-3.86M-
Extraordinary Items & Discontinued Operations-----
Enumeral Biomed Profit/ Loss (Net Income)
-11.85M3.29M-8.17M-3.86M-
Average Shares used to compute Diluted EPS56.19M52.37M32.05M--
Average Shares used to compute Basic EPS56.19M51.68M32.05M--
Income Before Nonrecurring Items-10.28M-1.86M-8.18M--
Income from Nonrecurring Items-1.58M5.15M---
Enumeral Biomed Earnings Per Share Basic Net
-0.210.06-0.26--
Enumeral Biomed Earnings Per Share Diluted Net
-0.210.06-0.26--
EPS Diluted Before Nonrecurring Items-0.18-0.04-0.26--
Preferred Dividends Acc Pd-----
Dividends Common-----
Dividend Per Share Common0.000.000.000.000.00
All figures in USD. M: Millions of USD, B: Billions of USD.

Click here to view our Shire financial analysis

Before investing one should read a report on Enumeral Biomed stock analysis. It helps to look at the following income statement items:

  • Top line: The word topline comes from the fact that the first line of an income statement refers to sales numbers. If you check you will find that ENUMQ stock has a topline or revenue of $2.45M for 2016 as per this Enumeral Biomed revenue chart. Investors look for stocks with a growing top line.
  • Bottom line: This refers to the last line in a profit and loss statement and denotes the net profit or loss for a particular period. The figure currently stands at $-11.85M for Enumeral Biomed for 2016. This figure is arrived at after deducting all operating expenses, interest, and taxes from revenue.

The income statement is also called statement of revenue and expense. The ENUMQ financials along with Enumeral Biomed historical stock prices provide a lot of details about the firm.

Enumeral Biomed Income Statement - Key Financial Ratios

Annual Income Statements - ENUMERAL BIOMEDICA COM USD0.001 Industry Peers

Imagenetix income statement, Pacifichealth income statement, Shire income statement